Shionogi and F2G report positive top line data from Phase III OASIS study
The randomised global study achieved its primary endpoint.
Clinical Trials
MAIA activates new site for THIO-101 Phase II trial
How wearables can unlock their full potential in clinical research
PhaseWell and LCTC to expand clinical trial access in Puerto Rico
First patient dosed in Deciphera’s Phase III INTREPID study
Edgewise reports positive top-line results from Phase II CIRRUS-HCM trial
Alpha Cognition begins enrolment in RESOLVE Phase IV trial for Zunveyl
XBiotech to commence V-SPINE trial enrolment for vilamakitug
